Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY20.33 CNY
Change Today +1.85 / 10.01%
Volume 24.8M
002099 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisoar pharm -a (002099) Snapshot

Open
CNY18.88
Previous Close
CNY18.48
Day High
CNY20.33
Day Low
CNY18.58
52 Week High
06/18/15 - CNY37.20
52 Week Low
12/22/14 - CNY7.95
Market Cap
15.4B
Average Volume 10 Days
22.8M
EPS TTM
CNY0.55
Shares Outstanding
757.8M
EX-Date
05/20/15
P/E TM
37.0x
Dividend
CNY0.20
Dividend Yield
0.98%
Current Stock Chart for ZHEJIANG HISOAR PHARM -A (002099)

Related News

No related news articles were found.

zhejiang hisoar pharm -a (002099) Related Businessweek News

No Related Businessweek News Found

zhejiang hisoar pharm -a (002099) Details

Zhejiang Hisoar Pharmaceutical Co., Ltd. produces and sells raw drugs and fine chemicals in China. The company offers raw drugs, such as antibody, anti-virus, cardiovascular, sugar-reducing, and worm-driven drugs for human and animal use; and fine chemicals, including medicine intermediates, and other customized and processed products. Its products primarily include clindamycin series, carbapenem series, thiamphenicol, florfenicol, voglibose, etc. The company also exports its products internationally. Zhejiang Hisoar Pharmaceutical Co., Ltd. is based in Taizhou, China.

zhejiang hisoar pharm -a (002099) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisoar pharm -a (002099) Key Developments

Zhejiang Hisoar Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Aug 27, 2015

Zhejiang Hisoar Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Aug 27, 2015

Zhejiang Hisoar Pharmaceutical Seeks Financicng

Zhejiang Hisoar Pharmaceutical Co., Ltd. (SZSE:002099) plans to raise up to CNY 2.1 billion in private placement of shares to fund projects.

Zhejiang Hisoar Pharmaceutical Co., Ltd. Amends its Articles of Association

Zhejiang Hisoar Pharmaceutical Co., Ltd. amended its articles of association at the AGM held on 06 May 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002099:CH CNY20.33 CNY +1.85

002099 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002099.
View Industry Companies
 

Industry Analysis

002099

Industry Average

Valuation 002099 Industry Range
Price/Earnings 29.8x
Price/Sales 7.2x
Price/Book 4.1x
Price/Cash Flow 39.6x
TEV/Sales 7.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISOAR PHARM -A, please visit www.hisoar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.